Several studies have reported that CD44-positivity is significantly associated with poor survival in gastric cancer patients [48,49,50], and presence of CD44-positive cancer stem-like cells especially at the invasive tumor front [51] act as an indicator of poor prognosis. This evidence concerns the gene CD44 and neoplasm.